Our Goal
BCOR seeks to develop a comprehensive clinical registry across Australia and New Zealand to improve the quality of care provided to patients diagnosed with bowel cancer which is the third commonest cancer by incidence.
Our Objectives:
Assess patterns of care
Reduce variation in treatment and outcome
Improve compliance with best-practice guidelines for the treatment of bowel cancer
Identify factors that predict favourable and unfavourable treatment outcomes, particularly in relation to major adverse effects
Provide information to patients about the risks and benefits of specific approaches to bowel cancer treatment.
Measuring outcomes that benefit patients and matter to Clinicians
Collecting a common data set of clinical measures across Australia and New Zealand enables reporting to clinicians and hospitals on outcomes and patterns of care that matter.
Through the provision of Annual Clinical Quality Reports, the Registry can:
Provide a cross-sectional view of clinical and demographic aspects of bowel cancer
Understand the uptake of evidence-based practice
Collect up-to-date information about patterns of care
See below for a complete list of Clinical Quality Indicators:
BCOR Clinical Quality Indicators
Measuring outcomes that matter to Patients
Improving the lives of patients with bowel cancer is at the heart of this initiative.
We use the validated questionnaires to capture how patients view their quality of life. Patient reported outcome surveys are collected prior to treatment (optional), and at 12 and perhaps 24 months post active treatment.
The Questionnaire Addresses:
Incontinence and associated bother.
Bowel function and associated bother.
For the first time, doctors and health professionals will be able to access patient experience data, transforming the treatment and care for patients diagnosed with bowel cancer.
Participating in BCOR
BCCA is made possible through collaboration with participating clinicians and public and private hospitals across Australia and New Zealand, who are committed to quality treatment and outcomes in prostate cancer.
By participating in BCOR, you commit to:
Provide explanatory information to patients and carers about the registry and its purpose
Provide data collectors and approved researchers with access to medical records stored in your hospital or clinical practice
Your valuable participation in BCOR will enable the registry to:
Support research at a population level that enables comparisons across Australia and New Zealand.
Provide risk adjusted, evidence-based reports to clinicians and hospitals on an annual cycle, based on a common set of clinical quality indicators.
Increase the implementation of best practice guidelines for treatment.
Assess patterns of care.
Reduce variation in patient outcomes.
Identify factors that predict better treatment outcomes.
Provide information to patients about the risks and benefits of specific approaches to bowel cancer treatment.
Participation is voluntary, however the more institutions and clinicians that support BCCA, the more effective it will be at ensuring the best possible health service to patients with bowel cancer.
If you wish to participate in BCOR, please contact your project co-ordinator Dr Hayat Dagher at contact@bowelcanceraudit.com.
Find out which doctors and hospitals are participating